Skip to main content
Erschienen in: Osteoporosis International 4/2014

01.04.2014 | Original Article

Association of matrix Gla protein gene functional polymorphisms with loss of bone mineral density and progression of aortic calcification

verfasst von: D. Tuñón-Le Poultel, J. B. Cannata-Andía, P. Román-García, J. B. Díaz-López, E. Coto, C. Gómez, M. Naves-Díaz, I. Rodríguez

Erschienen in: Osteoporosis International | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

Summary

Two matrix Gla protein (MGP) polymorphisms were associated with progression of aortic calcification and femoral neck bone loss in men. All these findings were also functionally corroborated in two vascular and bone in vitro systems indicating that MGP genetic variations can be partly responsible of higher risk of bone loss and vascular calcification.

Introduction

MGP plays an important role in bone and vascular mineralization as confirmed by MGP-deficient murine model. We therefore aimed to find a genetic association among -138T>C, -7G>A, and Thr83Ala MGP single-nucleotide polymorphisms (SNPs), bone loss, and progression of aortic calcification in a randomly selected general population of 296 individuals who participated in the European Vertebral Osteoporosis Study.

Methods

To evaluate the rate of change in bone mineral density (BMD) and the progression of aortic calcification, dual X-ray absorptiometry and lateral spine X-rays were performed at baseline and after 4 years of follow-up. Genotyping for the three polymorphisms was carried out using polymerase chain reaction and restriction fragment length analysis. In addition, functional studies of MGP-7G>A and Thr83Ala SNPs were performed on transiently transfected osteoblast-like UMR-106 and vascular smooth muscle A7r5 cells.

Results

The proportion of men who had lost BMD in the femoral neck was higher among homozygous -7AA and 83Ala-Ala (p = 0.039 and p = 0.009, respectively), and also featured a higher risk of progression of aortic calcifications (OR = 5.6, 95 % CI = 1.2–27.8 and OR = 6.8, 95 % CI = 1.4–32.3, respectively). No effect was observed in women. The MGP-7A allele produced a reduction in luciferase activity compared to MGP-7G: 47 % less in vascular cells and 34 % less in bone cells (p = 0.001 and 0.012, respectively). In vascular cells under calcifying conditions, the MGP 83Thr allele showed a slightly higher, although not significant, inhibition than the MGP 83 Ala allele in calcium content suggesting functional differences between both variants.

Conclusion

These results suggest that MGP genetic variations could predict a higher risk of bone loss and progression of vascular calcification in men.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Schinke T, McKee MD, Kiviranta R, Karsenty G (1998) Molecular determinants of arterial calcification. Ann Med 30:538–541PubMedCrossRef Schinke T, McKee MD, Kiviranta R, Karsenty G (1998) Molecular determinants of arterial calcification. Ann Med 30:538–541PubMedCrossRef
3.
Zurück zum Zitat Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V (2004) Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 89:4246–4253PubMedCrossRef Schulz E, Arfai K, Liu X, Sayre J, Gilsanz V (2004) Aortic calcification and the risk of osteoporosis and fractures. J Clin Endocrinol Metab 89:4246–4253PubMedCrossRef
4.
Zurück zum Zitat Naves M, Rodriguez-Garcia M, Diaz-Lopez JB, Gomez-Alonso C, Cannata-Andia JB (2008) Progression of vascular calcifications is associated with greater bone loss and increased bone fractures. Osteoporos Int 19:1161–1166PubMedCrossRef Naves M, Rodriguez-Garcia M, Diaz-Lopez JB, Gomez-Alonso C, Cannata-Andia JB (2008) Progression of vascular calcifications is associated with greater bone loss and increased bone fractures. Osteoporos Int 19:1161–1166PubMedCrossRef
5.
Zurück zum Zitat Neves KR, Graciolli FG, dos Reis LM, Pasqualucci CA, Moyses RM, Jorgetti V (2004) Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure. Kidney Int 66:2237–2244PubMedCrossRef Neves KR, Graciolli FG, dos Reis LM, Pasqualucci CA, Moyses RM, Jorgetti V (2004) Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure. Kidney Int 66:2237–2244PubMedCrossRef
6.
Zurück zum Zitat Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G (1997) Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386:78–81PubMedCrossRef Luo G, Ducy P, McKee MD, Pinero GJ, Loyer E, Behringer RR, Karsenty G (1997) Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386:78–81PubMedCrossRef
7.
Zurück zum Zitat Price PA, Urist MR, Otawara Y (1983) Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem Biophys Res Commun 117:765–771PubMedCrossRef Price PA, Urist MR, Otawara Y (1983) Matrix Gla protein, a new gamma-carboxyglutamic acid-containing protein which is associated with the organic matrix of bone. Biochem Biophys Res Commun 117:765–771PubMedCrossRef
8.
Zurück zum Zitat Roy ME, Nishimoto SK (2002) Matrix Gla protein binding to hydroxyapatite is dependent on the ionic environment: calcium enhances binding affinity but phosphate and magnesium decrease affinity. Bone 31:296–302PubMedCrossRef Roy ME, Nishimoto SK (2002) Matrix Gla protein binding to hydroxyapatite is dependent on the ionic environment: calcium enhances binding affinity but phosphate and magnesium decrease affinity. Bone 31:296–302PubMedCrossRef
9.
Zurück zum Zitat Zebboudj AF, Shin V, Bostrom K (2003) Matrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cells. J Cell Biochem 90:756–765PubMedCrossRef Zebboudj AF, Shin V, Bostrom K (2003) Matrix GLA protein and BMP-2 regulate osteoinduction in calcifying vascular cells. J Cell Biochem 90:756–765PubMedCrossRef
10.
Zurück zum Zitat Munroe PB, Olgunturk RO, Fryns JP, Van Maldergem L, Ziereisen F, Yuksel B, Gardiner RM, Chung E (1999) Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet 21:142–144PubMedCrossRef Munroe PB, Olgunturk RO, Fryns JP, Van Maldergem L, Ziereisen F, Yuksel B, Gardiner RM, Chung E (1999) Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet 21:142–144PubMedCrossRef
11.
Zurück zum Zitat Meier M, Weng LP, Alexandrakis E, Ruschoff J, Goeckenjan G (2001) Tracheobronchial stenosis in Keutel syndrome. Eur Respir J 17:566–569PubMedCrossRef Meier M, Weng LP, Alexandrakis E, Ruschoff J, Goeckenjan G (2001) Tracheobronchial stenosis in Keutel syndrome. Eur Respir J 17:566–569PubMedCrossRef
12.
Zurück zum Zitat Herrmann SM, Whatling C, Brand E et al (2000) Polymorphisms of the human matrix gla protein (MGP) gene, vascular calcification, and myocardial infarction. Arterioscler Thromb Vasc Biol 20:2386–2393PubMedCrossRef Herrmann SM, Whatling C, Brand E et al (2000) Polymorphisms of the human matrix gla protein (MGP) gene, vascular calcification, and myocardial infarction. Arterioscler Thromb Vasc Biol 20:2386–2393PubMedCrossRef
13.
Zurück zum Zitat Brancaccio D, Biondi ML, Gallieni M, Turri O, Galassi A, Cecchini F, Russo D, Andreucci V, Cozzolino M (2005) Matrix GLA protein gene polymorphisms: clinical correlates and cardiovascular mortality in chronic kidney disease patients. Am J Nephrol 25:548–552PubMedCrossRef Brancaccio D, Biondi ML, Gallieni M, Turri O, Galassi A, Cecchini F, Russo D, Andreucci V, Cozzolino M (2005) Matrix GLA protein gene polymorphisms: clinical correlates and cardiovascular mortality in chronic kidney disease patients. Am J Nephrol 25:548–552PubMedCrossRef
14.
Zurück zum Zitat Crosier MD, Booth SL, Peter I, Dawson-Hughes B, Price PA, O’Donnell CJ, Hoffmann U, Williamson MK, Ordovas JM (2009) Matrix Gla protein polymorphisms are associated with coronary artery calcification in men. J Nutr Sci Vitaminol (Tokyo) 55:59–65CrossRef Crosier MD, Booth SL, Peter I, Dawson-Hughes B, Price PA, O’Donnell CJ, Hoffmann U, Williamson MK, Ordovas JM (2009) Matrix Gla protein polymorphisms are associated with coronary artery calcification in men. J Nutr Sci Vitaminol (Tokyo) 55:59–65CrossRef
15.
Zurück zum Zitat Cassidy-Bushrow AE, Bielak LF, Levin AM, Sheedy PF 2nd, Turner ST, Boerwinkle E, Lin X, Kardia SL, Peyser PA (2013) Matrix Gla protein gene polymorphism is associated with increased coronary artery calcification progression. Arterioscler Thromb Vasc Biol 33:645–651PubMedCentralPubMedCrossRef Cassidy-Bushrow AE, Bielak LF, Levin AM, Sheedy PF 2nd, Turner ST, Boerwinkle E, Lin X, Kardia SL, Peyser PA (2013) Matrix Gla protein gene polymorphism is associated with increased coronary artery calcification progression. Arterioscler Thromb Vasc Biol 33:645–651PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Misra D, Booth SL, Crosier MD, Ordovas JM, Felson DT, Neogi T (2011) Matrix Gla protein polymorphism, but not concentrations, is associated with radiographic hand osteoarthritis. J Rheumatol 38:1960–1965PubMedCentralPubMedCrossRef Misra D, Booth SL, Crosier MD, Ordovas JM, Felson DT, Neogi T (2011) Matrix Gla protein polymorphism, but not concentrations, is associated with radiographic hand osteoarthritis. J Rheumatol 38:1960–1965PubMedCentralPubMedCrossRef
17.
Zurück zum Zitat Tsukamoto K, Orimo H, Hosoi T, Miyao M, Yoshida H, Watanabe S, Suzuki T, Emi M (2000) Association of bone mineral density with polymorphism of the human matrix Gla protein locus in elderly women. J Bone Miner Metab 18:27–30PubMedCrossRef Tsukamoto K, Orimo H, Hosoi T, Miyao M, Yoshida H, Watanabe S, Suzuki T, Emi M (2000) Association of bone mineral density with polymorphism of the human matrix Gla protein locus in elderly women. J Bone Miner Metab 18:27–30PubMedCrossRef
18.
Zurück zum Zitat O’Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ (1996) The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 11:1010–1018PubMedCrossRef O’Neill TW, Felsenberg D, Varlow J, Cooper C, Kanis JA, Silman AJ (1996) The prevalence of vertebral deformity in European men and women: the European Vertebral Osteoporosis Study. J Bone Miner Res 11:1010–1018PubMedCrossRef
19.
Zurück zum Zitat Frye MA, Melton LJ 3rd, Bryant SC, Fitzpatrick LA, Wahner HW, Schwartz RS, Riggs BL (1992) Osteoporosis and calcification of the aorta. Bone Miner 19:185–194PubMedCrossRef Frye MA, Melton LJ 3rd, Bryant SC, Fitzpatrick LA, Wahner HW, Schwartz RS, Riggs BL (1992) Osteoporosis and calcification of the aorta. Bone Miner 19:185–194PubMedCrossRef
20.
21.
Zurück zum Zitat Jono S, Nishizawa Y, Shioi A, Morii H (1998) 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 98:1302–1306PubMedCrossRef Jono S, Nishizawa Y, Shioi A, Morii H (1998) 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 98:1302–1306PubMedCrossRef
22.
Zurück zum Zitat Maniatis T, Fistch E, Sambrook J (1989) Molecular cloning. Cold Spring Harbor Laboratory Press, New York Maniatis T, Fistch E, Sambrook J (1989) Molecular cloning. Cold Spring Harbor Laboratory Press, New York
23.
Zurück zum Zitat Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25:402–408PubMedCrossRef Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25:402–408PubMedCrossRef
24.
Zurück zum Zitat Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21:2933–2942PubMedCrossRef Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21:2933–2942PubMedCrossRef
25.
Zurück zum Zitat Heinemeyer T, Wingender E, Reuter I et al (1998) Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 26:362–367PubMedCentralPubMedCrossRef Heinemeyer T, Wingender E, Reuter I et al (1998) Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. Nucleic Acids Res 26:362–367PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat McFarlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR (2004) Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link? Endocrine 23:1–10PubMedCrossRef McFarlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR (2004) Osteoporosis and cardiovascular disease: brittle bones and boned arteries, is there a link? Endocrine 23:1–10PubMedCrossRef
27.
Zurück zum Zitat Cannata-Andia JB, Roman-Garcia P, Hruska K (2011) The connections between vascular calcification and bone health. Nephrol Dial Transplant 26:3429–3436PubMedCrossRef Cannata-Andia JB, Roman-Garcia P, Hruska K (2011) The connections between vascular calcification and bone health. Nephrol Dial Transplant 26:3429–3436PubMedCrossRef
29.
Zurück zum Zitat Naves-Diaz M, Cabezas-Rodriguez I, Barrio-Vazquez S, Fernandez E, Diaz-Lopez JB, Cannata-Andia JB (2012) Low calcidiol levels and risk of progression of aortic calcification. Osteoporos Int 23:1177–1182PubMedCrossRef Naves-Diaz M, Cabezas-Rodriguez I, Barrio-Vazquez S, Fernandez E, Diaz-Lopez JB, Cannata-Andia JB (2012) Low calcidiol levels and risk of progression of aortic calcification. Osteoporos Int 23:1177–1182PubMedCrossRef
30.
Zurück zum Zitat Estrada K, Styrkarsdottir U, Evangelou E et al (2012) Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 44:491–501PubMedCentralPubMedCrossRef Estrada K, Styrkarsdottir U, Evangelou E et al (2012) Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet 44:491–501PubMedCentralPubMedCrossRef
31.
Zurück zum Zitat Raouf A, Seth A (2000) Ets transcription factors and targets in osteogenesis. Oncogene 19:6455–6463PubMedCrossRef Raouf A, Seth A (2000) Ets transcription factors and targets in osteogenesis. Oncogene 19:6455–6463PubMedCrossRef
32.
Zurück zum Zitat Ceppioglu SK, Yurdun T, Canbakan M (2011) Assessment of matrix Gla protein, Klotho gene polymorphisms, and oxidative stress in chronic kidney disease. Ren Fail 33:866–874 Ceppioglu SK, Yurdun T, Canbakan M (2011) Assessment of matrix Gla protein, Klotho gene polymorphisms, and oxidative stress in chronic kidney disease. Ren Fail 33:866–874
33.
Zurück zum Zitat Gao B, Yasui T, Itoh Y, Tozawa K, Hayashi Y, Kohri K (2007) A polymorphism of matrix Gla protein gene is associated with kidney stones. J Urol 177:2361–2365PubMedCrossRef Gao B, Yasui T, Itoh Y, Tozawa K, Hayashi Y, Kohri K (2007) A polymorphism of matrix Gla protein gene is associated with kidney stones. J Urol 177:2361–2365PubMedCrossRef
34.
Zurück zum Zitat Hale JE, Williamson MK, Price PA (1991) Carboxyl-terminal proteolytic processing of matrix Gla protein. J Biol Chem 266:21145–21149PubMed Hale JE, Williamson MK, Price PA (1991) Carboxyl-terminal proteolytic processing of matrix Gla protein. J Biol Chem 266:21145–21149PubMed
35.
Zurück zum Zitat Kaipatur NR, Murshed M, McKee MD (2008) Matrix Gla protein inhibition of tooth mineralization. J Dent Res 87:839–844PubMedCrossRef Kaipatur NR, Murshed M, McKee MD (2008) Matrix Gla protein inhibition of tooth mineralization. J Dent Res 87:839–844PubMedCrossRef
36.
Zurück zum Zitat Yagami K, Suh JY, Enomoto-Iwamoto M, Koyama E, Abrams WR, Shapiro IM, Pacifici M, Iwamoto M (1999) Matrix GLA protein is a developmental regulator of chondrocyte mineralization and, when constitutively expressed, blocks endochondral and intramembranous ossification in the limb. J Cell Biol 147:1097–1108PubMedCentralPubMedCrossRef Yagami K, Suh JY, Enomoto-Iwamoto M, Koyama E, Abrams WR, Shapiro IM, Pacifici M, Iwamoto M (1999) Matrix GLA protein is a developmental regulator of chondrocyte mineralization and, when constitutively expressed, blocks endochondral and intramembranous ossification in the limb. J Cell Biol 147:1097–1108PubMedCentralPubMedCrossRef
37.
Zurück zum Zitat Barone LM, Owen TA, Tassinari MS, Bortell R, Stein GS, Lian JB (1991) Developmental expression and hormonal regulation of the rat matrix Gla protein (MGP) gene in chondrogenesis and osteogenesis. J Cell Biochem 46:351–365PubMedCrossRef Barone LM, Owen TA, Tassinari MS, Bortell R, Stein GS, Lian JB (1991) Developmental expression and hormonal regulation of the rat matrix Gla protein (MGP) gene in chondrogenesis and osteogenesis. J Cell Biochem 46:351–365PubMedCrossRef
38.
Zurück zum Zitat Reid IR, Evans MC, Ames R, Wattie DJ (1991) The influence of osteophytes and aortic calcification on spinal mineral density in postmenopausal women. J Clin Endocrinol Metab 72:1372–1374PubMedCrossRef Reid IR, Evans MC, Ames R, Wattie DJ (1991) The influence of osteophytes and aortic calcification on spinal mineral density in postmenopausal women. J Clin Endocrinol Metab 72:1372–1374PubMedCrossRef
Metadaten
Titel
Association of matrix Gla protein gene functional polymorphisms with loss of bone mineral density and progression of aortic calcification
verfasst von
D. Tuñón-Le Poultel
J. B. Cannata-Andía
P. Román-García
J. B. Díaz-López
E. Coto
C. Gómez
M. Naves-Díaz
I. Rodríguez
Publikationsdatum
01.04.2014
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 4/2014
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-013-2577-1

Weitere Artikel der Ausgabe 4/2014

Osteoporosis International 4/2014 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.